RECURRENT MENINGIOMA
Clinical trials for RECURRENT MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MENINGIOMA trials appear
Sign up with your email to follow new studies for RECURRENT MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to halt recurring brain tumor growth
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to precise radiation (stereotactic radiosurgery) can help control recurrent meningioma, a type of brain tumor. About 35 adults with grade II or III meningioma that has returned after prior treatments will receiv…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE2 • Sponsor: Nancy Ann Oberheim Bush, MD • Aim: Disease control
Last updated May 26, 2026 04:24 UTC
-
New Imaging-Guided radiation aims to tackle tough brain tumors
Disease control TerminatedThis early-phase study tests whether giving higher doses of radiation, guided by special PET and MRI scans, is safe for people with high-risk meningiomas (aggressive or returning brain tumors). About 24 adults will receive one of four radiation dose levels to find the highest dos…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New combo therapy offers hope for aggressive brain tumor
Disease control OngoingThis study tests two immunotherapy drugs (nivolumab and ipilimumab) combined with precise radiation for people with a recurrent, high-grade meningioma (a type of brain tumor). The goal is to find the safest dose and see if the treatment can shrink tumors or slow their growth. Abo…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
New radioactive therapy targets Hard-to-Treat brain tumors
Disease control TerminatedThis study tests a radioactive drug called RYZ101 for people with meningioma brain tumors that have come back or are growing despite standard treatments. The drug targets a protein found on these tumor cells and delivers radiation to kill them. The trial involves 30 adults and ai…
Matched conditions: RECURRENT MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Joshua Palmer • Aim: Disease control
Last updated May 18, 2026 12:03 UTC